COVID-19 SARS-CoV-2 preprints from medRxiv and bioRxiv

31,024 Articles (22,627 medRxiv, 8,397 bioRxiv)

Most recent first Previous |  Page 8: Articles 71-80  | Next

A Systematic Review of Spatial Epidemiological Modeling Approaches Applied During the COVID-19 Pandemic
Oshinubi, K., Chen, Y., Doerry, E., Gel, E. S., Hepp, C. M., Lant, T. M., Mehrotra, S., Sabo, S., Mihaljevic, J. R.
10.1101/2025.09.24.25336493 — Posted: 2025-09-25
Late treatment initiation leads to reduced antiviral potency
Liu, X., Franco, E. J., Avedissian, S. N., Hanrahan, K. C., Guedj, J., van Hasselt, J. G. C., Brown, A. N., Martson, A.-G.
10.1101/2025.09.24.678199 — Posted: 2025-09-25
SARS-CoV-2 ORF7a Drives Mitochondrial Dysfunction via PDK4 Activation and Complex I Inhibition
Fernandez-Rodriguez, R., Soto-Jimenez, C. M., Acin-Perez, R., de Lucas-Rius, A., Sanchez-Mendoza, L. M., Lopez-Ayllon, B. D., Villalba, J. M., Enriquez, J. A., Montoya, M., Garrido, J. J., Garcia-Garcia, T.
10.1101/2025.09.25.678549 — Posted: 2025-09-25
Changes in Age-Specific Pregnancy Prevalence Proportions over the Covid-19 Pandemic in Manicaland, Zimbabwe
Gregson, S., Moorhouse, L. R., Maswera, R., Bagnay, S., Tsenesa, B., Mandizvidza, P., Morris, R., Nyamukapa, C. A.
10.1101/2025.09.23.25336434 — Posted: 2025-09-24
The Evolution of Long COVID Research, 2020 to 2025: A Bibliometric Analysis with Implications for Clinical Practice and Policy
Daodu, L. P., Ajanaku, N., Ojeikere, K. I., Ozokolie, G. E., Okouzi, M., Ogunbiyi, O. J., Onah, C. M., Olotu, M., Chibuoke, H. C., Erameh, M.
10.1101/2025.09.23.25336485 — Posted: 2025-09-24
Factors associated with psycho- and pharmacotherapy initiation for common mental disorders in the general population during the COVID-19 pandemic
Pouquet, M., Vuillermoz, C., Debin, M., Davisse-Paturet, C., Kengne-Kuetche, C., Turbelin, C., Blanchon, T., Tournier, M., Steichen, O., Younes, N.
10.1101/2025.09.22.25336319 — Posted: 2025-09-24
How many crystal structures do you need to trust your docking results?
Payne, A. M., Kaminow, B., MacDermott-Opeskin, H., Pulido, I., Scheen, J., Castellanos, M. A., Fearon, D., Chodera, J. D., Singh, S.
10.1101/2025.09.19.677428 — Posted: 2025-09-24
VSA-2, a novel plant-derived adjuvant for SARS-CoV-2 subunit vaccine
Adam, A., Lee, C., Jones, M. C., Harrington, B. R., Zou, J., Peng, B.-H., Xie, X., Wang, P., Wang, T.
10.1101/2025.09.22.677856 — Posted: 2025-09-24
A Novel dual Influenza virus and SARS-CoV-2 neutralisation assay
da Costa, K. A. S., Mayora-Neto, M., Adigun, S. F., Shobande, T. T., Amoaka-Tawiah, D., Masud, S., Basaru-Sanni, T. O., Coopoomootoo, P., Jones, A. W., Davison, G., Pjechova, M., Miller, A. D., Fajfr, M., Ruzek, D., Temperton, N. J.
10.1101/2025.09.19.677384 — Posted: 2025-09-23
Redirection of SARS-CoV-2 to phagocytes by intranasal sACE2-Fc as a universal decoy confers complete prophylactic protection
Wang, J., Li, J., Chin, A. W., Luo, B., Wei, J., Qiu, J., Ren, J., Xia, Y., Braun, T., L M Poon, L. L. M., Feng, B.
10.1101/2025.09.23.677998 — Posted: 2025-09-23

RSS  Collection RSS | JSON

The feeds linked above output metadata for the 100 most recent papers in the collection.To access the metadata for the entire collection in JSON or XML, visit the collection API.

Subject Areas
* The Clinical Trials and Epidemiology subject categories are now closed to new submissions following the completion of bioRxiv's clinical research pilot project and launch of the dedicated health sciences server medRxiv (submit.medrxiv.org). New papers that report results of Clinical Trials must now be submitted to medRxiv. Most new Epidemiology papers also should be submitted to medRxiv, but if a paper contains no health-related information, authors may choose to submit it to another bioRxiv subject category (e.g., Genetics or Microbiology).